Surface Logix

About:

Surface Logix is a drug development company using biophysical chemistry to create new small molecule drugs.

Website: http://www.surfacelogix.com

Top Investors: ARCH Venture Partners, Intel Capital, Venrock, Silicon Valley Bank, MPM Capital

Description:

Surface Logix is a drug development company which uses its expertise in biophysical chemistry to create new small molecule drugs with significantly improved pharmacokinetic (PK) and pharmacodynamic (PD) properties compared with class leaders.

Total Funding Amount:

$101M

Headquarters Location:

Brighton, Massachusetts, United States

Founded Date:

1999-01-01

Contact Email:

info(AT)surfacelogix.com

Founders:

Carmichael Roberts

Number of Employees:

1-10

Last Funding Date:

2010-07-16

IPO Status:

Private

Industries:

© 2025 bioDAO.ai